Trial Profile

The Multicenter Study for Effects of Eplerenone on Cardiac Diastolic Dysfunction in Hypertensive Patients

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 05 Apr 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Eplerenone (Primary)
Indications Diastolic heart failure; Hypertension
Focus Biomarker; Pharmacodynamics
Acronyms MELODY

Most Recent Events

03 Apr 2017 Planned End Date changed from 1 Jan 2015 to 30 Jun 2017.
27 Mar 2016 Status changed from recruiting to active, no longer recruiting.
09 Oct 2013 Planned number of patients changed from 400 to 180 as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com